1085157

Akorn, Inc. — FEI 3003102962

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 5, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Gurnee, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)